APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral OTC Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral OTC Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025188 pages

Choose your research edition.

Industry ResearchOral OTC Analgesics Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral OTC Analgesics Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Oral OTC Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral OTC Analgesics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral OTC Analgesics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Oral OTC Analgesics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral OTC Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral OTC Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral OTC Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral OTC Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral OTC Analgesics include Takeda Pharmaceutical Company, Sun Pharmaceutical Industries, Sanofi, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer and Reckitt Benckiser, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral OTC Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral OTC Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral OTC Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral OTC Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral OTC Analgesics Segment by Company

Takeda Pharmaceutical Company

Sun Pharmaceutical Industries

Sanofi

Johnson & Johnson

Novartis

Pfizer

GlaxoSmithKline

Bayer

Reckitt Benckiser

Oral OTC Analgesics Segment by Type

Acetaminophen (TYLENOL)

Salicylates

Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Oral OTC Analgesics Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Oral OTC Analgesics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral OTC Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral OTC Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral OTC Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral OTC Analgesics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral OTC Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral OTC Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral OTC Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral OTC Analgesics Industry Trends Table 2. Oral OTC Analgesics Industry Drivers Table 3. Oral OTC Analgesics Industry Opportunities and Challenges Table 4. Oral OTC Analgesics Industry Restraints Table 5. Global Oral OTC Analgesics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral OTC Analgesics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral OTC Analgesics Sales by Manufacturers (kg) & (2021-2026) Table 8. Global Oral OTC Analgesics Sales Market Share by Manufacturers Table 9. Global Oral OTC Analgesics Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Oral OTC Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral OTC Analgesics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral OTC Analgesics Manufacturers, Product Type & Application Table 13. Global Oral OTC Analgesics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral OTC Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Acetaminophen (TYLENOL) Table 17. Major Manufacturers of Salicylates Table 18. Major Manufacturers of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Table 19. Global Oral OTC Analgesics Sales by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Oral OTC Analgesics Sales by Type (2021-2026) & (kg) Table 21. Global Oral OTC Analgesics Sales by Type (2027-2032) & (kg) Table 22. Global Oral OTC Analgesics Sales Market Share by Type (2021-2026) Table 23. Global Oral OTC Analgesics Sales Market Share by Type (2027-2032) Table 24. Global Oral OTC Analgesics Revenue by Type 2021 VS 2025 VS 2032 (kg) Table 25. Global Oral OTC Analgesics Revenue by Type (2021-2026) & (kg) Table 26. Global Oral OTC Analgesics Revenue by Type (2027-2032) & (kg) Table 27. Global Oral OTC Analgesics Revenue Market Share by Type (2021-2026) Table 28. Global Oral OTC Analgesics Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Online Pharmacies Table 30. Major Manufacturers of Hospital Pharmacies Table 31. Major Manufacturers of Retail Pharmacies Table 32. Global Oral OTC Analgesics Sales by Application 2021 VS 2025 VS 2032 (kg) Table 33. Global Oral OTC Analgesics Sales by Application (2021-2026) & (kg) Table 34. Global Oral OTC Analgesics Sales by Application (2027-2032) & (kg) Table 35. Global Oral OTC Analgesics Sales Market Share by Application (2021-2026) Table 36. Global Oral OTC Analgesics Sales Market Share by Application (2027-2032) Table 37. Global Oral OTC Analgesics Revenue by Application 2021 VS 2025 VS 2032 (kg) Table 38. Global Oral OTC Analgesics Revenue by Application (2021-2026) & (kg) Table 39. Global Oral OTC Analgesics Revenue by Application (2027-2032) & (kg) Table 40. Global Oral OTC Analgesics Revenue Market Share by Application (2021-2026) Table 41. Global Oral OTC Analgesics Revenue Market Share by Application (2027-2032) Table 42. Global Oral OTC Analgesics Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 43. Global Oral OTC Analgesics Sales by Region (2021-2026) & (kg) Table 44. Global Oral OTC Analgesics Sales Market Share by Region (2021-2026) Table 45. Global Oral OTC Analgesics Sales Forecasted by Region (2027-2032) & (kg) Table 46. Global Oral OTC Analgesics Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Oral OTC Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 48. North America Oral OTC Analgesics Sales by Country (2021-2026) & (kg) Table 49. North America Oral OTC Analgesics Sales by Country (2027-2032) & (kg) Table 50. Europe Oral OTC Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 51. Europe Oral OTC Analgesics Sales by Country (2021-2026) & (kg) Table 52. Europe Oral OTC Analgesics Sales by Country (2027-2032) & (kg) Table 53. Asia Pacific Oral OTC Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 54. Asia Pacific Oral OTC Analgesics Sales by Country (2021-2026) & (kg) Table 55. Asia Pacific Oral OTC Analgesics Sales by Country (2027-2032) & (kg) Table 56. South America, Middle East and Africa Oral OTC Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 57. South America, Middle East and Africa Oral OTC Analgesics Sales by Country (2021-2026) & (kg) Table 58. South America, Middle East and Africa Oral OTC Analgesics Sales by Country (2027-2032) & (kg) Table 59. Global Oral OTC Analgesics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Oral OTC Analgesics Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Oral OTC Analgesics Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Oral OTC Analgesics Revenue Market Share by Region (2021-2026) Table 63. Global Oral OTC Analgesics Revenue Market Share by Region (2027-2032) Table 64. Takeda Pharmaceutical Company Company Information Table 65. Takeda Pharmaceutical Company Business Overview Table 66. Takeda Pharmaceutical Company Oral OTC Analgesics Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Takeda Pharmaceutical Company Oral OTC Analgesics Product Portfolio Table 68. Takeda Pharmaceutical Company Recent Development Table 69. Sun Pharmaceutical Industries Company Information Table 70. Sun Pharmaceutical Industries Business Overview Table 71. Sun Pharmaceutical Industries Oral OTC Analgesics Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sun Pharmaceutical Industries Oral OTC Analgesics Product Portfolio Table 73. Sun Pharmaceutical Industries Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Oral OTC Analgesics Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sanofi Oral OTC Analgesics Product Portfolio Table 78. Sanofi Recent Development Table 79. Johnson & Johnson Company Information Table 80. Johnson & Johnson Business Overview Table 81. Johnson & Johnson Oral OTC Analgesics Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Johnson & Johnson Oral OTC Analgesics Product Portfolio Table 83. Johnson & Johnson Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis Oral OTC Analgesics Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Novartis Oral OTC Analgesics Product Portfolio Table 88. Novartis Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Oral OTC Analgesics Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Pfizer Oral OTC Analgesics Product Portfolio Table 93. Pfizer Recent Development Table 94. GlaxoSmithKline Company Information Table 95. GlaxoSmithKline Business Overview Table 96. GlaxoSmithKline Oral OTC Analgesics Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. GlaxoSmithKline Oral OTC Analgesics Product Portfolio Table 98. GlaxoSmithKline Recent Development Table 99. Bayer Company Information Table 100. Bayer Business Overview Table 101. Bayer Oral OTC Analgesics Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Bayer Oral OTC Analgesics Product Portfolio Table 103. Bayer Recent Development Table 104. Reckitt Benckiser Company Information Table 105. Reckitt Benckiser Business Overview Table 106. Reckitt Benckiser Oral OTC Analgesics Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Reckitt Benckiser Oral OTC Analgesics Product Portfolio Table 108. Reckitt Benckiser Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Oral OTC Analgesics Distributors List Table 112. Oral OTC Analgesics Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Oral OTC Analgesics Product Image Figure 2. Global Oral OTC Analgesics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral OTC Analgesics Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral OTC Analgesics Sales (2021-2032) & (kg) Figure 5. Global Oral OTC Analgesics Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Oral OTC Analgesics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Acetaminophen (TYLENOL) Image Figure 9. Salicylates Image Figure 10. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Image Figure 11. Global Oral OTC Analgesics Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Oral OTC Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Oral OTC Analgesics Sales Market Share by Type (2021-2032) Figure 14. Global Oral OTC Analgesics Revenue by Type (2021 VS 2025 VS 2032) & (kg) Figure 15. Global Oral OTC Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Oral OTC Analgesics Revenue Market Share by Type (2021-2032) Figure 17. Online Pharmacies Image Figure 18. Hospital Pharmacies Image Figure 19. Retail Pharmacies Image Figure 20. Global Oral OTC Analgesics Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 21. Global Oral OTC Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Oral OTC Analgesics Sales Market Share by Application (2021-2032) Figure 23. Global Oral OTC Analgesics Revenue by Application (2021 VS 2025 VS 2032) & (kg) Figure 24. Global Oral OTC Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Oral OTC Analgesics Revenue Market Share by Application (2021-2032) Figure 26. North America Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 27. North America Oral OTC Analgesics Sales Market Share by Country (2021-2032) Figure 28. U.S. Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 29. Canada Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 30. Mexico Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 31. Europe Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 32. Europe Oral OTC Analgesics Sales Market Share by Country (2021-2032) Figure 33. Germany Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 34. France Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 35. U.K. Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 36. Italy Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 37. Netherlands Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 38. Asia Pacific Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 39. Asia Pacific Oral OTC Analgesics Sales Market Share by Country (2021-2032) Figure 40. China Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 41. Japan Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 42. South Korea Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 43. Southeast Asia Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 44. India Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 45. Australia Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 46. South America, Middle East and Africa Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 47. South America, Middle East and Africa Oral OTC Analgesics Sales Market Share by Country (2021-2032) Figure 48. Brazil Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 49. South Africa Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 50. Saudi Arabia Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 51. Turkey Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 52. Argentina Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 53. UAE Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 54. Egypt Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 55. Chile Oral OTC Analgesics Sales and Growth Rate (2021-2032) & (kg) Figure 56. Global Oral OTC Analgesics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Oral OTC Analgesics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Oral OTC Analgesics Revenue (2021-2032) & (US$ Million) Figure 59. North America Oral OTC Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Oral OTC Analgesics Revenue (2021-2032) & (US$ Million) Figure 61. Europe Oral OTC Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Oral OTC Analgesics Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Oral OTC Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Oral OTC Analgesics Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Oral OTC Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Oral OTC Analgesics Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Oral OTC Analgesics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Acetaminophen (TYLENOL)
  • Salicylates
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Takeda Pharmaceutical Company
  • Sun Pharmaceutical Industries
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Reckitt Benckiser

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral OTC Analgesics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral OTC Analgesics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral OTC Analgesics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral OTC Analgesics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral OTC Analgesics Market Dynamics
  1. 2.1 Oral OTC Analgesics Industry Trends
  2. 2.2 Oral OTC Analgesics Industry Drivers
  3. 2.3 Oral OTC Analgesics Industry Opportunities and Challenges
  4. 2.4 Oral OTC Analgesics Industry Restraints
3 Oral OTC Analgesics Market by Manufacturers
  1. 3.1 Global Oral OTC Analgesics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral OTC Analgesics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral OTC Analgesics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral OTC Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral OTC Analgesics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral OTC Analgesics Manufacturers, Product Type & Application
  7. 3.7 Global Oral OTC Analgesics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral OTC Analgesics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral OTC Analgesics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral OTC Analgesics Tier 1, Tier 2, and Tier 3
4 Oral OTC Analgesics Market by Type
  1. 4.1 Oral OTC Analgesics Type Introduction
  2. 4.1.1 Acetaminophen (TYLENOL)
  3. 4.1.2 Salicylates
  4. 4.1.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  5. 4.2 Global Oral OTC Analgesics Sales by Type
  6. 4.2.1 Global Oral OTC Analgesics Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Oral OTC Analgesics Sales by Type (2021-2032)
  8. 4.2.3 Global Oral OTC Analgesics Sales Market Share by Type (2021-2032)
  9. 4.3 Global Oral OTC Analgesics Revenue by Type
  10. 4.3.1 Global Oral OTC Analgesics Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Oral OTC Analgesics Revenue by Type (2021-2032)
  12. 4.3.3 Global Oral OTC Analgesics Revenue Market Share by Type (2021-2032)
5 Oral OTC Analgesics Market by Application
  1. 5.1 Oral OTC Analgesics Application Introduction
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Oral OTC Analgesics Sales by Application
  6. 5.2.1 Global Oral OTC Analgesics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral OTC Analgesics Sales by Application (2021-2032)
  8. 5.2.3 Global Oral OTC Analgesics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Oral OTC Analgesics Revenue by Application
  10. 5.3.1 Global Oral OTC Analgesics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Oral OTC Analgesics Revenue by Application (2021-2032)
  12. 5.3.3 Global Oral OTC Analgesics Revenue Market Share by Application (2021-2032)
6 Global Oral OTC Analgesics Sales by Region
  1. 6.1 Global Oral OTC Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral OTC Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Oral OTC Analgesics Sales by Region (2021-2026)
  4. 6.2.2 Global Oral OTC Analgesics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral OTC Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral OTC Analgesics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral OTC Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral OTC Analgesics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral OTC Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral OTC Analgesics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral OTC Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral OTC Analgesics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral OTC Analgesics Revenue by Region
  1. 7.1 Global Oral OTC Analgesics Revenue by Region
  2. 7.1.1 Global Oral OTC Analgesics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral OTC Analgesics Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral OTC Analgesics Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral OTC Analgesics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral OTC Analgesics Revenue (2021-2032)
  8. 7.2.2 North America Oral OTC Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral OTC Analgesics Revenue (2021-2032)
  11. 7.3.2 Europe Oral OTC Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral OTC Analgesics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral OTC Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral OTC Analgesics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral OTC Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Company
  2. 8.1.1 Takeda Pharmaceutical Company Company Information
  3. 8.1.2 Takeda Pharmaceutical Company Business Overview
  4. 8.1.3 Takeda Pharmaceutical Company Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Company Oral OTC Analgesics Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 8.2 Sun Pharmaceutical Industries
  8. 8.2.1 Sun Pharmaceutical Industries Company Information
  9. 8.2.2 Sun Pharmaceutical Industries Business Overview
  10. 8.2.3 Sun Pharmaceutical Industries Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Industries Oral OTC Analgesics Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Industries Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Oral OTC Analgesics Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Oral OTC Analgesics Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Oral OTC Analgesics Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Oral OTC Analgesics Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Oral OTC Analgesics Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Oral OTC Analgesics Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Reckitt Benckiser
  50. 8.9.1 Reckitt Benckiser Company Information
  51. 8.9.2 Reckitt Benckiser Business Overview
  52. 8.9.3 Reckitt Benckiser Oral OTC Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Reckitt Benckiser Oral OTC Analgesics Product Portfolio
  54. 8.9.5 Reckitt Benckiser Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral OTC Analgesics Value Chain Analysis
  2. 9.1.1 Oral OTC Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral OTC Analgesics Production Mode & Process
  6. 9.2 Oral OTC Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral OTC Analgesics Distributors
  9. 9.2.3 Oral OTC Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst